annual total liabilities:
$1.27B+$720.38M(+132.14%)Summary
- As of today (August 18, 2025), GMAB annual total liabilities is $1.27 billion, with the most recent change of +$720.38 million (+132.14%) on December 31, 2024.
- During the last 3 years, GMAB annual total liabilities has risen by +$893.85 million (+240.48%).
- GMAB annual total liabilities is now at all-time high.
Performance
GMAB Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$1.16B-$128.00M(-9.92%)Summary
- As of today (August 18, 2025), GMAB quarterly total liabilities is $1.16 billion, with the most recent change of -$128.00 million (-9.92%) on June 1, 2025.
- Over the past year, GMAB quarterly total liabilities has increased by +$62.60 million (+5.69%).
- GMAB quarterly total liabilities is now -9.92% below its all-time high of $1.29 billion, reached on March 31, 2025.
Performance
GMAB quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
GMAB Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +132.1% | +5.7% |
| 3 y3 years | +240.5% | +176.1% |
| 5 y5 years | +668.7% | +174.2% |
GMAB Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +240.5% | -9.9% | +185.4% |
| 5 y | 5-year | at high | +668.7% | -9.9% | +253.9% |
| alltime | all time | at high | >+9999.0% | -9.9% | >+9999.0% |
GMAB Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $1.16B(-9.9%) |
| Mar 2025 | - | $1.29B(+1.9%) |
| Dec 2024 | $1.27B(+132.1%) | $1.27B(+9.2%) |
| Sep 2024 | - | $1.16B(+5.4%) |
| Jun 2024 | - | $1.10B(+81.5%) |
| Mar 2024 | - | $605.66M(+11.1%) |
| Dec 2023 | $545.17M(+33.9%) | $545.17M(-6.9%) |
| Sep 2023 | - | $585.81M(+24.0%) |
| Jun 2023 | - | $472.24M(+1.1%) |
| Mar 2023 | - | $467.29M(+14.8%) |
| Dec 2022 | $407.16M(+9.5%) | $407.16M(-23.3%) |
| Sep 2022 | - | $530.84M(+26.1%) |
| Jun 2022 | - | $420.90M(+28.2%) |
| Mar 2022 | - | $328.33M(-11.7%) |
| Dec 2021 | $371.70M(+11.8%) | $371.70M(-11.7%) |
| Sep 2021 | - | $420.82M(+18.3%) |
| Jun 2021 | - | $355.79M(+6.5%) |
| Mar 2021 | - | $334.23M(+0.6%) |
| Dec 2020 | $332.37M(+101.9%) | $332.37M(-30.7%) |
| Sep 2020 | - | $479.70M(+13.2%) |
| Jun 2020 | - | $423.75M(+218.4%) |
| Mar 2020 | - | $133.07M(-19.2%) |
| Dec 2019 | $164.64M(+140.6%) | $164.64M(+38.2%) |
| Sep 2019 | - | $119.10M(+13.0%) |
| Jun 2019 | - | $105.40M(+15.3%) |
| Mar 2019 | - | $91.38M(+33.6%) |
| Dec 2018 | $68.42M(+28.3%) | $68.42M(+35.3%) |
| Sep 2018 | - | $50.55M(-4.7%) |
| Jun 2018 | - | $53.03M(+22.2%) |
| Mar 2018 | - | $43.39M(-18.6%) |
| Dec 2017 | $53.34M(-8.6%) | $53.34M(-21.6%) |
| Sep 2017 | - | $68.05M(-24.7%) |
| Jun 2017 | - | $90.38M(+57.3%) |
| Mar 2017 | - | $57.44M(-1.6%) |
| Dec 2016 | $58.38M(-3.6%) | $58.38M(-7.7%) |
| Sep 2016 | - | $63.23M(+11.5%) |
| Jun 2016 | - | $56.69M(-4.9%) |
| Mar 2016 | - | $59.63M(-1.5%) |
| Dec 2015 | $60.53M(-55.3%) | $60.53M(-12.4%) |
| Sep 2015 | - | $69.12M(-10.0%) |
| Jun 2015 | - | $76.79M(-9.0%) |
| Mar 2015 | - | $84.40M(-37.7%) |
| Dec 2014 | $135.49M(-31.6%) | $135.49M(-11.0%) |
| Sep 2014 | - | $152.28M(-14.3%) |
| Jun 2014 | - | $177.68M(-6.3%) |
| Mar 2014 | - | $189.66M(-4.2%) |
| Dec 2013 | $198.00M(-14.4%) | $198.00M(-15.0%) |
| Sep 2013 | - | $232.99M(+13.3%) |
| Jun 2013 | - | $205.62M(-5.7%) |
| Mar 2013 | - | $218.16M(-5.7%) |
| Dec 2012 | $231.43M | $231.43M(-4.5%) |
| Sep 2012 | - | $242.25M(+41.5%) |
| Jun 2012 | - | $171.21M(-7.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $184.81M(-1.8%) |
| Dec 2011 | $188.29M(-25.4%) | $188.29M(-8.2%) |
| Sep 2011 | - | $205.21M(-9.9%) |
| Jun 2011 | - | $227.87M(-3.8%) |
| Mar 2011 | - | $236.82M(-6.1%) |
| Dec 2010 | $252.30M(+41.6%) | $252.30M(+5.0%) |
| Sep 2010 | - | $240.29M(+94.7%) |
| Jun 2010 | - | $123.44M(-21.7%) |
| Mar 2010 | - | $157.66M(-11.5%) |
| Dec 2009 | $178.23M(-10.8%) | $178.23M(+6.1%) |
| Sep 2009 | - | $167.96M(-14.5%) |
| Jun 2009 | - | $196.52M(+5.6%) |
| Mar 2009 | - | $186.12M(-6.9%) |
| Dec 2008 | $199.90M(-5.2%) | - |
| Dec 2008 | - | $199.90M(-3.0%) |
| Sep 2008 | - | $206.11M(-10.2%) |
| Jun 2008 | - | $229.51M(+1.3%) |
| Mar 2008 | - | $226.53M(+7.4%) |
| Dec 2007 | $210.88M(+505.0%) | - |
| Dec 2007 | - | $210.88M(-1.3%) |
| Sep 2007 | - | $213.69M(+2.8%) |
| Jun 2007 | - | $207.93M(-4.6%) |
| Mar 2007 | - | $218.05M(+525.6%) |
| Dec 2006 | $34.86M(-12.4%) | - |
| Dec 2006 | - | $34.86M(-11.4%) |
| Sep 2006 | - | $39.36M(+0.8%) |
| Jun 2006 | - | $39.05M(-1.8%) |
| Mar 2006 | - | $39.78M(-0.0%) |
| Dec 2005 | $39.80M(+139.5%) | - |
| Dec 2005 | - | $39.80M(-13.1%) |
| Sep 2005 | - | $45.78M(+128.4%) |
| Jun 2005 | - | $20.05M(+4.5%) |
| Mar 2005 | - | $19.19M(+15.5%) |
| Dec 2004 | $16.61M(+4.7%) | - |
| Dec 2004 | - | $16.61M(-11.2%) |
| Sep 2004 | - | $18.71M(-1.0%) |
| Jun 2004 | - | $18.90M(+21.4%) |
| Mar 2004 | - | $15.58M(-1.8%) |
| Dec 2003 | $15.87M(-38.9%) | - |
| Dec 2003 | - | $15.87M(+3.6%) |
| Sep 2003 | - | $15.32M(-12.7%) |
| Jun 2003 | - | $17.55M(-0.2%) |
| Mar 2003 | - | $17.59M(+27.5%) |
| Dec 2002 | $25.99M(+117.7%) | - |
| Sep 2002 | - | $13.80M(+8.5%) |
| Jun 2002 | - | $12.73M(+7.6%) |
| Mar 2002 | - | $11.83M(-0.9%) |
| Dec 2001 | $11.94M(+20.9%) | $11.94M(+21.6%) |
| Sep 2001 | - | $9.82M(-9.5%) |
| Jun 2001 | - | $10.85M(+11.3%) |
| Mar 2001 | - | $9.75M |
| Dec 2000 | $9.87M(+2916.2%) | - |
| Dec 1999 | $327.30K | - |
FAQ
- What is Genmab A/S annual total liabilities?
- What is the all time high annual total liabilities for Genmab A/S?
- What is Genmab A/S annual total liabilities year-on-year change?
- What is Genmab A/S quarterly total liabilities?
- What is the all time high quarterly total liabilities for Genmab A/S?
- What is Genmab A/S quarterly total liabilities year-on-year change?
What is Genmab A/S annual total liabilities?
The current annual total liabilities of GMAB is $1.27B
What is the all time high annual total liabilities for Genmab A/S?
Genmab A/S all-time high annual total liabilities is $1.27B
What is Genmab A/S annual total liabilities year-on-year change?
Over the past year, GMAB annual total liabilities has changed by +$720.38M (+132.14%)
What is Genmab A/S quarterly total liabilities?
The current quarterly total liabilities of GMAB is $1.16B
What is the all time high quarterly total liabilities for Genmab A/S?
Genmab A/S all-time high quarterly total liabilities is $1.29B
What is Genmab A/S quarterly total liabilities year-on-year change?
Over the past year, GMAB quarterly total liabilities has changed by +$62.60M (+5.69%)